| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |